BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Eleven Therapeutics Ltd.

Headquarters: Tel Aviv, Israel
Year Founded: 2020
Status: Private

BioCentury | Jan 12, 2024
Management Tracks

Ajer leaving BioMarin as head of commercial

Plus: Paloma Giangrande named CTO at Eleven and updates from LenioBio and Depixus
BioCentury | Oct 13, 2023
Politics, Policy & Law

Biotech in a time of war

Israel’s biotechs are resilient, determined to continue
BioCentury | Aug 3, 2022
Finance

Aug. 2 Quick Takes: Yescarta label expansion buoys Gilead’s 2Q22 sales

Plus Megaround for Sironax, and updates from Eleven, Roche, Axcella, Phathom, and more
BioCentury | Feb 8, 2022
Finance

Feb. 7 Quick Takes: WuXi Biologics shares fall after landing on Commerce list

Plus mega-rounds for Endeavor, Dewpoint and updates from Koneksa, ObsEva and more
BioCentury | Oct 20, 2021
Finance

NFX seeks to seed more platforms at the tech-bio intersection

With its third and largest fund, early investor in Twist and Mammoth aims to bulk up its NFX Bio portfolio  
Items per page:
1 - 5 of 5